{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T20:56:47Z","timestamp":1760648207614,"version":"3.44.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,31]]},"DOI":"10.7759\/cureus.91354","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:43:52Z","timestamp":1756687432000},"source":"Crossref","is-referenced-by-count":1,"title":["A Preventable Adverse Reaction: Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome Following Allopurinol Use for Asymptomatic Hyperuricemia"],"prefix":"10.7759","author":[{"given":"Hadiza","family":"Ibrahim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghada","family":"Rashwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adil","family":"Jumani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hana","family":"Purra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alhasssan","family":"Alteneiji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed","family":"Hussaini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2011.01.017","article-title":"The DRESS syndrome: a literature review","volume":"124","author":"Cacoub P","year":"2011","unstructured":"Cacoub P, Musette P, Descamps V, Meyer O, Speirs C, Finzi L, Roujeau JC. The DRESS syndrome: a literature review. Am J Med. 2011, 124:588-97. 10.1016\/j.amjmed.2011.01.017","journal-title":"Am J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18061243","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): an interplay among drugs, viruses, and the immune system","volume":"18","author":"Cho YT","year":"2017","unstructured":"Cho YT, Yang CW, Chu CY. Drug reaction with eosinophilia and systemic symptoms (DRESS): an interplay among drugs, viruses, and the immune system. Int J Mol Sci. 2017, 18:10.3390\/ijms18061243","journal-title":"Int J Mol Sci"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.01.033","article-title":"DRESS syndrome: Part I. Clinical perspectives","volume":"68","author":"Husain Z","year":"2013","unstructured":"Husain Z, Reddy BY, Schwartz RA. DRESS syndrome: Part I. Clinical perspectives. J Am Acad Dermatol. 2013, 68:693.e1-14; quiz 706-8. 10.1016\/j.jaad.2013.01.033","journal-title":"J Am Acad Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0409500102","article-title":"HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol","volume":"102","author":"Hung SI","year":"2005","unstructured":"Hung SI, Chung WH, Liou LB, et al.. HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. Proc Natl Acad Sci U S A. 2005, 102:4134-9. 10.1073\/pnas.0409500102","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/art.30596","article-title":"Inflammation and autoantibody markers identify rheumatoid arthritis patients with enhanced clinical benefit following rituximab treatment","volume":"63","author":"Lal P","year":"2011","unstructured":"Lal P, Su Z, Holweg CT, et al.. Inflammation and autoantibody markers identify rheumatoid arthritis patients with enhanced clinical benefit following rituximab treatment. Arthritis Rheum. 2011, 63:3681-91. 10.1002\/art.30596","journal-title":"Arthritis Rheum"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/acr.24180","article-title":"2020 American College of Rheumatology guideline for the management of gout","volume":"72","author":"FitzGerald JD","year":"2020","unstructured":"FitzGerald JD, Dalbeth N, Mikuls T, et al.. 2020 American College of Rheumatology guideline for the management of gout. Arthritis Care Res (Hoboken). 2020, 72:744-60. 10.1002\/acr.24180","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2015.3536","article-title":"Allopurinol use and risk of fatal hypersensitivity reactions: a nationwide population-based study in Taiwan","volume":"175","author":"Yang CY","year":"2015","unstructured":"Yang CY, Chen CH, Deng ST, et al.. Allopurinol use and risk of fatal hypersensitivity reactions: a nationwide population-based study in Taiwan. JAMA Intern Med. 2015, 175:1550-7. 10.1001\/jamainternmed.2015.3536","journal-title":"JAMA Intern Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12501","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study","volume":"169","author":"Kardaun SH","year":"2013","unstructured":"Kardaun SH, Sekula P, Valeyrie-Allanore L, et al.. Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study. Br J Dermatol. 2013, 169:1071-80. 10.1111\/bjd.12501","journal-title":"Br J Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2020.0814","article-title":"Evaluation of cyclosporine for the treatment of DRESS syndrome","volume":"156","author":"Nguyen E","year":"2020","unstructured":"Nguyen E, Yanes D, Imadojemu S, Kroshinsky D. Evaluation of cyclosporine for the treatment of DRESS syndrome. JAMA Dermatol. 2020, 156:704-6. 10.1001\/jamadermatol.2020.0814","journal-title":"JAMA Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s40629-022-00207-9","article-title":"Treatment with IL-5\/IL-5 receptor antagonists in drug reaction with eosinophilia and systemic symptoms (DRESS)","volume":"32","author":"Gschwend A","year":"2022","unstructured":"Gschwend A, Helbling A, Feldmeyer L, et al.. Treatment with IL-5\/IL-5 receptor antagonists in drug reaction with eosinophilia and systemic symptoms (DRESS). Allergo J Int. 2022, 32:79-85. 10.1007\/s40629-022-00207-9","journal-title":"Allergo J Int"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2008.03.031","article-title":"The role of scalp dermoscopy in the diagnosis of alopecia areata incognita","volume":"59","author":"Tosti A","year":"2008","unstructured":"Tosti A, Whiting D, Iorizzo M, Pazzaglia M, Misciali C, Vincenzi C, Micali G. The role of scalp dermoscopy in the diagnosis of alopecia areata incognita. J Am Acad Dermatol. 2008, 59:64-7. 10.1016\/j.jaad.2008.03.031","journal-title":"J Am Acad Dermatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2018.08.013","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome identified in a large electronic health record database","volume":"7","author":"Wolfson AR","year":"2019","unstructured":"Wolfson AR, Zhou L, Li Y, Phadke NA, Chow OA, Blumenthal KG. Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome identified in a large electronic health record database. J Allergy Clin Immunol Pract. 2019, 7:633-40. 10.1016\/j.jaip.2018.08.013","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-69054-7","article-title":"Viral reactivation and clinical outcomes in drug reaction with eosinophilia and systemic symptoms (DRESS): a multicenter study","volume":"14","author":"Chan LC","year":"2024","unstructured":"Chan LC, Sultana R, Choo KJ, Yeo YW, Pang SM, Lee HY. Viral reactivation and clinical outcomes in drug reaction with eosinophilia and systemic symptoms (DRESS): a multicenter study. Sci Rep. 2024, 14:28492. 10.1038\/s41598-024-69054-7","journal-title":"Sci Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/388457-a-preventable-adverse-reaction-drug-reaction-with-eosinophilia-and-systemic-symptoms-dress-syndrome-following-allopurinol-use-for-asymptomatic-hyperuricemia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:43:56Z","timestamp":1756687436000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/388457-a-preventable-adverse-reaction-drug-reaction-with-eosinophilia-and-systemic-symptoms-dress-syndrome-following-allopurinol-use-for-asymptomatic-hyperuricemia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,31]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.91354","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,31]]}}}